Mr. Steinberger, a veteran trial attorney with extensive experience in entertainment and
mass product liability litigation, is the founder and senior partner of The Law Offices of Jeffrey W. Steinberger, A Professional Corporation.
Not exact matches
Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases in the build rates of certain aircraft; 6) the effect on aircraft demand and build rates of changing customer preferences for business aircraft, including the effect of global economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect of changes in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical
mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future
litigation, claims, and regulatory actions; 30) exposure to potential
product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations in foreign current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.
Rob handles complex
litigation matters, including catastrophic personal injury,
product liability, class action,
mass tort, and commercial disputes.
John concentrates his practice on representing corporate clients in tort defense,
products liability,
mass torts, class actions, toxic torts, asbestos,
litigation management, food
liability, professional
liability, pharmaceutical and medical device
litigation, environmental
litigation, intellectual property
litigation, construction defect
litigation, general
liability, premises
liability, and business and insurance disputes.
His practice covers a range of
litigation, including commercial, class action defense,
product liability,
mass tort, environmental, trade secret, insurance coverage, and real property title disputes in state and federal courts.
While much of his practice has focused on the
litigation of
mass / toxic tort matters,
product liability and premises
liability, Tim has also handled cases arising out of maritime and port operations.
V Andre Sherman is a trial lawyer specializing in the areas of
product liability, pharmaceutical
mass torts, consumer and employment class actions, and business
litigation.
Lum defends clients in
product liability and
mass tort
litigation, putative class actions, personal injury cases, and long - term care facility and nursing home
litigation.
He has many years of experience representing a variety of clients ranging from Fortune 500 companies to small business owners in all phases of
litigation including complex commercial cases, corporations, contracts, deceptive trade practices,
mass toxic tort cases, premises
liability,
products liability, and general civil
litigation.
She has experience defending clients in
product liability and
mass tort
litigation, putative class actions, personal injury cases, and long - term care and nursing home
litigation.
He concentrates his practice in complex
litigation, nursing home cases, personal injury,
product liability,
mass tort, Jones Act, and railroad (FELA) injuries.
We have deep, relevant experience in
product liability and
mass and toxic tort
litigation that we can bring to bear to handle formaldehyde - related claims.
He concentrates his practice in general civil
litigation with a particular emphasis on e-discovery,
mass tort
litigation and
products liability.
He has also represented corporations in professional malpractice, breach of contract, consumer rights, real estate, civil rights,
product liability, construction, whistleblower, medical malpractice, class action and
mass tort
litigation.
Enjolique Aytch —
Litigation Practice Group, Fort Lauderdale Enjolique Aytch focuses her practice on products liability and mass tort l
Litigation Practice Group, Fort Lauderdale Enjolique Aytch focuses her practice on
products liability and
mass tort
litigationlitigation.
Since 2003, Erin has gained invaluable experience in personal injury and
products liability litigation; experience that has allowed her to develop distinctive approaches to nationally - recognized
mass tort media campaigns, comprehensive client management and streamlined settlement administration.
The firm, which has grown to 80 attorneys with offices in Long Beach, San Francisco, Seattle, Anchorage, and Hong Kong, has developed expertise in many specialties of civil
litigation including class and
mass actions, securities and banking
litigation, mortgage
litigation, employment, energy, environmental, admiralty and maritime, bankruptcy, business
litigation,
products liability, real estate, toxic tort, professional malpractice defense, professional design & construction, all types of civil appeals, mortgage banking, real estate, corporate / transactional and other commercial matters.
These law firms were a reaction to the rise in Plaintiff's law firms retooled to gather the technical information and expertise (often gathered by government agencies and burgeoning universities fueled by GI Bill enrollment) that was needed to prosecute
product liability cases and
mass torts and to manage massive amounts of discovery and class action lawsuit in this complex
litigation.
Named «Best Lawyers» 2018 «Oklahoma City Lawyers of the Year» were Timothy J. Bomhoff for
product liability litigation defense, W. Chris Coleman for both securities regulation and venture capital law, Robert W. Dace for
mass tort
litigation / class actions defense, Elizabeth L. Dalton for franchise law, Spencer W. Haines for closely held companies and family businesses law, Henry D. Hoss for construction
litigation, and Susan B. Shields for tax
litigation and controversy.
His practice focuses largely on the
litigation of complex disputes involving common law, statutory law, contract law, physician and hospital
liability law,
products liability law, commercial, corporate and business issues, catastrophic personal injury cases and class action /
mass torts / pharmaceutical
litigation.
Las Vegas Trial Lawyer — Erica D. Entsminger Erica is a partner on the
mass torts team and her practice focuses on
mass tort
litigation, complex
product liability cases and multi-district
litigation.
These factors have persuaded numerous companies to retain us as lead or coordinating counsel for their most complex
product liability and
mass tort
litigations.
Mr. Sistrunk's practice focuses largely on the
litigation of complex disputes involving common law, statutory law, contract law, physician and hospital
liability law,
product liability law, commercial, corporate and business issues, catastrophic personal injury cases and class action /
mass torts / pharmaceutical
litigation.
GM ignition switch ruling; dangers of RV fuel systems; litigating Section 8 housing cases; maximizing recoveries in bad faith claims; tire failures and rollover accidents; spotting a
product liability claim; courtroom hurdles in traumatic brain injury cases; conspicuity issues in trucking accident cases;
mass torts updates related to 3M Biar Hugger warming blankets, talcum powder
litigation, Taxotere claims and Zofran.
Prior to joining Lewis Wagner, Meghan was an associate in the New York firm Traub Lieberman Straus & Shrewsberry's insurance coverage group, where she represented insurance company clients in insurance coverage
litigation, and advised insurers on exposure and
liability issues in wide array of tort and commercial contexts, including
mass tort and class action
litigation involving pharmaceuticals, chemical, transportation, news and entertainment, and oil and gas; environmental suits; FDA compliance claims; unfair competition and false advertising claims; intellectual property claims; construction defect; personal injury;
product liability; and associated breach of contract claims.
With a practice focused on commercial
litigation and the defense of
product manufacturers in
mass tort and
products liability matters, Elan Hersh advises clients on electronic discovery (eDiscovery), information governance,
litigation readiness and response, cross-border discovery issues, and data...
At Conroy Simberg, we are proud of our firm's nationwide reputation for delivering highly effective defense counsel in asbestos
litigation matters, as well as
mass tort and
products liability cases, including silica claims.
His experience includes
product liability, commercial and business
litigation, real estate
litigation, insurance coverage disputes, personal injury defense, counseling on corporate and individual insurance claims issues,
mass tort
litigation, work site accidents, defense of premises
liability claims, and construction and building materials defects.
Ned's practice includes
mass tort
product liability litigation, personal injury, medical malpractice, and business
litigation.
He is experienced in healthcare - related employment disputes,
products liability cases, multi-district
litigation, and
mass - torts.
Our attorneys are consistently recognized as Lawyer of the Year and Top Lawyer in their respective practice areas, earning spots on the «Best Lawyers» and «Super Lawyers» rosters for their experience in personal injury,
product liability, trucking accident, railroad and
mass torts
litigation.
Jonathan's practice is focused on
mass tort
product liability litigation involving defective medical devices and pharmaceutical drugs.
Fellow firm attorney Christopher T. Kirchmer was named to the exclusive guide for his representation of plaintiffs in
mass tort
litigation, class actions, and personal injury and
product liability litigation.
Levin Papantonio Shareholder Timothy O'Brien is a board - certified civil trial attorney who concentrates his practice in the areas of
mass tort
litigation,
product liability, personal injury, wrongful death, and transactional
liability.
Ms. Goldstein focuses her practice in the areas of personal injury, medical malpractice,
product liability,
mass torts and class action
litigation.
We have decades of experience advising clients on risk management and compliance, and defending against class action,
mass tort, multidistrict
litigation, and individual actions alleging toxic tort and
product liability claims.
He focuses his practice in the areas of
products liability defense,
mass torts, and other complex tort
litigation as well as employment law and corresponding
litigation.
Marisa K. Pearson is an associate with MG+M, whose practice focuses on complex civil
litigation, including toxic tort,
mass tort, and
products liability defense.
He advises large national corporations on complex
litigation in the areas of
product liability defense,
mass tort defense, class action and multidistrict
litigation, as well as regional companies and locally owned concerns, in court cases in both state and federal systems.
At Gomez Trial Attorneys we specialize in personal injury,
products liability,
mass tort, and environmental, insurance, and corporate
litigation.
Our practice areas include pharmaceutical
mass torts, commercial
litigation, automotive
products liability, and other personal injury.
Brent M. Karren, a partner in the firm, practices in the area of complex tort
litigation with a broad focus in
products liability, insurance defense, premises
liability and
mass tort
litigation involving asbestos, and toxic tort
liability.
His complex
litigation experience also includes parallel criminal / civil cases, class actions, securities,
mass tort matters, and managing the national defense of 100's of
product liability cases.
If You need a Rhode Island Personal injury lawyer who has extensive experience dealing with
product liability,
mass tort, medical malpractice and defective drug
litigation.
Currently, Mrs. Adams focuses her practice on personal injury,
mass tort
litigation,
products liability litigation, wrongful death, and admiralty / maritime law.
His experience in
products liability litigation encompasses
mass torts involving latex gloves, cough and cold medications, antibiotics, food flavorings, hypertension medications and anti-coagulants.
His practice is devoted primarily to
litigation matters where he focuses on various
product liability, personal injury and complex
mass tort cases.
The firm also acts as national trial counsel and provides national coordinating services and risk management for clients in the areas of
mass toxic tort,
products liability, personal injury, environmental regulation and
litigation.»
Corporate
Litigation Counsel: Ms. Sedney has acted as outside corporate litigation counsel in a variety of contexts including wrongful death litigation, breach of contract claims, alleged asbestos exposure, general tort litigation, product liability and mass tort l
Litigation Counsel: Ms. Sedney has acted as outside corporate
litigation counsel in a variety of contexts including wrongful death litigation, breach of contract claims, alleged asbestos exposure, general tort litigation, product liability and mass tort l
litigation counsel in a variety of contexts including wrongful death
litigation, breach of contract claims, alleged asbestos exposure, general tort litigation, product liability and mass tort l
litigation, breach of contract claims, alleged asbestos exposure, general tort
litigation, product liability and mass tort l
litigation,
product liability and
mass tort
litigationlitigation.
Juanita R. Brooks, a Principal of the firm and an elected member of the firm's Management Committee, is a nationally recognized trial and appellate lawyer who specializes in complex intellectual property,
product liability, and
mass tort
litigation.